Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ICCC |
---|---|---|
09:55 ET | 566 | 4.4601 |
10:31 ET | 100 | 4.63 |
10:58 ET | 300 | 4.555 |
11:56 ET | 4500 | 4.56 |
11:57 ET | 2000 | 4.55 |
12:01 ET | 900 | 4.55 |
12:06 ET | 506 | 4.55 |
02:07 ET | 3147 | 4.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ImmuCell Corp | 35.3M | -5.6x | --- |
Celularity Inc | 40.5M | -0.4x | --- |
LAVA Therapeutics NV | 40.2M | -0.8x | --- |
Molecular Templates Inc | 26.9M | -0.7x | --- |
DURECT Corp | 19.7M | -0.4x | --- |
Avalo Therapeutics Inc | 12.4M | 0.0x | --- |
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line, providing Immediate Immunity for the prevention of scours in newborn dairy and beef calves. It expanded this line into four different products with formulations targeting E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. This product line provides Immediate Immunity to newborn calves. The Company is engaged in the development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. The Company’s products reduce the use of traditional antibiotics in food producing animals.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $35.3M |
---|---|
Revenue (TTM) | $16.3M |
Shares Outstanding | 7.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.60 |
EPS | $-0.81 |
Book Value | $3.92 |
P/E Ratio | -5.6x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.